Skip to main content
Clinical Trials/JPRN-UMIN000052372
JPRN-UMIN000052372
Completed
未知

Comparative study for the effect of test diets on the absorption and excretion of the body water and electrolytes. -an open-label, randomized, two-periods crossover comparative trial- - Comparative study for the effect of test diets on the absorption and excretion of the body water and electrolytes. -an open-label, randomized, two-periods crossover comparative trial

IMEQRD Co., Ltd0 sites20 target enrollmentOctober 10, 2023

Overview

Phase
未知
Intervention
Not specified
Conditions
Heat stress disorder
Sponsor
IMEQRD Co., Ltd
Enrollment
20
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 10, 2023
End Date
November 8, 2023
Last Updated
2 years ago
Study Type
Interventional
Sex
Male

Investigators

Sponsor
IMEQRD Co., Ltd

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\. Have been taking foods or supplements with functional health claims, which affect the study outcome, such as capsaicin, spices, or any stimulus functional foods for blood flow or body temperature improvement, more than three times a week, and who can't also discontinue intake of these foods. 2\. Currently receive medical treatments with drugs. Medications used as needed are acceptable. 3\. Alcohol drinking over an average of 40 g/day per week. 4\. Have difficulty with blood sampling. 5\. Those who have a tattoo. 6\. Have difficulty with sweating in a sauna bath. 7\. Those whose weight does not fluctuate due to sweating 8\. Those who can't enter a sauna bath for ten minutes three times. 9\. Those who can't enter a sauna bath for one person due to claustrophobia. 10\. Have a scar for a burn injury in a wide area on the body. 11\. Have severe diseases or a history of severe diseases in the heart, liver, kidney, or digestive organs. 12\. Have allergies to drugs or foods. 13\. Those who joined other clinical trials four weeks before, those who have currently joined other clinical trials, and who are planning to join other clinical trials after the consent acquisition in the study. 14\. Have above 200 mL blood donation within one month before the start period of the study. 15\. Have above 400 mL blood donation within three months before the start period of the study. 16\. Have above 1200 mL blood donation volume, which is the sum of the planned blood donation volume in the study and the previous donated blood volume within twelve months before the start period of the study. 17\. Those who are unsuitable for the study, judged by the principal investigator.

Outcomes

Primary Outcomes

Not specified

Similar Trials